Drug · DIN 02485974
LORBRENA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 22, 2019; first marketed April 22, 2019.
- Drug Identification Number (DIN)
- 02485974
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lorlatinib L01ED05
- Class
- Human
- Record last updated
- April 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LORLATINIB | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 22, 2019: NOC 21896New Drug Submission (NDS)
Other DINs named LORBRENA
- DIN 02485966 · Marketed